Grant received in 2024.
DCCC has funded 112,500 DKK to the project.
When cancer spreads to the pleura and peritoneum, it is most often a sign of end-stage disease. Unfortunately, many primary cancers (stomach, colorectal, ovarian, pancreatic, lung and breast) are prone to disseminate into the pleura and peritoneum. The problem is substantial, the prognosis is poor and, with few exceptions, treatments are solely palliative. There is an urgent need for new initiatives that can contribute to prevention, early detection, and the development of new treatments to improve survival chances.
Due to the complex and varied nature of these cancer types, there is a need for increased multidisciplinary and national efforts. The purpose of this initiative is to gather a national expert group for interdisciplinary discussions on the current treatment situation and specific opportunities for research and development. The goal is to garner support for the establishment of a permanent national expert group open to all with an interest in this important yet often overlooked patient group.
Multidisciplinary organisation
This initiative is not affiliated with any specific DMCG, as it focuses on patients with metastases to the pleura and peritoneum, which are not covered by an individual DMCG. The initiative is anchored in the Odense PIPAC Center (OPC), a multidisciplinary group that has been researching the prevention and treatment of metastases to the pleura and peritoneum for the past 8 years.
Project stakeholders
Oncologists
- Laurids Østergaard Poulsen, Consultant, Aalborg University Hospital
- Anne Ramlov, Consultant, Aarhus University Hospital
- Gabor Liposits, Consultant, Gødstrup Hospital
- Lene Bæksgaard Jensen, Consultant, Righospitalet
- Jakob Hagen Vasehus Schou, Consultant, Herlev Hospital
- Per Pfeiffer, Professor, Odense University Hospital
- Line Schmidt Tarpgaard, Consultant, Odense University Hospital
Surgeons
- Alan Ainsworth, Consultant, Odense University Hospital
- Michael Bau Mortensen, Professor, Odense University Hospital. Primary contact, e-mail: michael.bau.mortensen@rsyd.dk
- Martin Graversen, MD, Odense University Hospital
Pathologist
- Sönke Detlefsen, Professor, Odense University Hospital
Nuclear medicine/radiology:
- Malene Grubbe Hildebrandt, Professor, Odense University Hospital
Patient/relative representatives:
- Thomas Samsing Rossen
- Henrik Christian Meyer
Registered Nurse
- Sofie Hald Nielsen, Odense University Hospital